Smoking cessation has proven to be a challenge for HIV-positive smokers. Patient and provider characteristics may provide barriers to smoking cessation. We aimed to identify characteristics associated with interest in cessation as well as characterize use of, current interest in, and provider recommendations for smoking cessation modalities. Data came from 275 HIV-positive smokers recruited online. Half (49.1%) of the sample was interested in quitting; daily smoking was associated with decreased likelihood of interest in cessation, whereas making a lifetime quit attempt, receiving encouragement to quit from an HIV care provider, and greater frequency of discussions regarding cessation with HIV care providers were associated with increased likelihood of interest in cessation. Nicotine replacement therapy was the most commonly used (42.9%), generated the most interest (59.1%), and was the most commonly clinicianrecommended (70.7%) cessation modality. Findings emphasize the importance of the healthcare provider-patient relationship for smoking cessation promotion in HIV-positive smokers.
Introduction
Cigarette smoking is highly prevalent (40%-75%) among persons living with HIV (PLWH) (Mdodo et al., 2015; Pacek, Harrell, & Martins, 2014; Pacek, Latkin, Crum, Stuart, & Knowlton, 2014a) . Among PLWH, smoking is associated with poor health (Freiberg et al., 2010; Madeddu et al., 2013; Vandenhende et al., 2015) , poor adherence to and decreased effectiveness of antiretroviral therapy, and poor HIV treatment outcomes (Feldman et al., 2006; O'Cleirigh et al., 2015; Shuter & Bernstein, 2008) . Smokers with HIV lose more life years to smoking than to HIV (Helleberg et al., 2013) .
Most (63%-74%) HIV-positive smokers are interested in quitting (Mamary, Bahrs, & Martinez, 2002; Pacek, Latkin, Crum, Stuart, & Knowlton, 2014b) . However, characteristics of HIV care providers may impede cessation. Compared to non-HIV care providers, they are less likely to assess patients' smoking status or interest in quitting (Duval et al., 2008; Tesoriero, Gieryic, Carrascal, & Lavigne, 2010) , which may stem from beliefs that patients lack interest in quitting (Horvath, Eastman, Prosser, Goodroad, & Worthington, 2012; Tesoriero et al., 2010) , limited smoking cessation training (Konfino, Mejia, & Basombrio, 2012; Shuter, Salmo, et al., 2012) , and limited confidence in their ability to impact smoking behavior (Crothers et al., 2007) . Healthcare providers represent a critical link to smoking cessation interventionsparticularly for PLWH, who routinely have contact with healthcare providers. Two studies suggest that HIV-positive smokers are more likely to attempt cessation following HIV diagnosis if a healthcare provider implements a cessation intervention (Berg et al., 2014) and experiencing a physician-delivered smoking status assessment increases readiness to quit (Amiya et al., 2011) . Beyond this, little is known about how patient-provider interactions impact interest in quitting smoking among PLWH.
We explored the influence of sociodemographics, substance use, and interaction with healthcare providers on interest in quitting smoking. We also characterized lifetime use of and interest in smoking modalities and characterize the modalities recommended by HIV care providers.
Methods

Data source
Data were from an online surveyadvertised/conducted on Amazon Mechanical Turk (MTurk). To participate, individuals registered on MTurk were required to have a ≥95% approval rating from prior MTurk tasks, be ≥18 years old, and reside in the United States.
Participants completed a screening questionnaire to determine eligibility, including: lifetime HIV diagnosis; having smoked ≥100 lifetime cigarettes; and having smoked ≥ one cigarette within the past month. Eligible participants were given a code to access the survey, hosted by Qualtrics (Provo, UT). The survey was active from March 16-May 14, 2015. Participation was voluntary and anonymous. The Johns Hopkins University Institutional Review Board approved this study.
Measures
Sociodemographic characteristics
Sociodemographic variables included sex, age, race, income, marital status, and education.
HIV characteristics
We assessed participants' age at and length of time since HIV diagnosis. Participants reported current use of antiretroviral therapy (yes/no).
Smoking characteristics
We assessed participants' CPD, days smoked within the past month, and past month daily smoking. Participants reported age at smoking initiation, number of years of smoking, and lifetime cessation attempt(s). Summing participants' time to first cigarette (TTFC) upon waking (<5 min = 3, 5-30 min = 2, 31-60 min = 1, >60 min = 0) and CPD (≤10 = 0; 11-20 = 1; 21-30 = 2; ≥31 = 3) produced the Heaviness of Smoking Index (HSI; (Heatherton, Kozlowski, Frecker, Rickert, & Robinson, 1989) .
Interest in and reasons for smoking cessation
Participants reported current interest in quitting smoking (yes/no). Individuals who responded "yes" were shown a list of 26 "reasons why someone might want to quit smoking completely." Participants selected all that applied and their most important reason.
Lifetime use of and interest in smoking cessation modalities
Participants reported lifetime use of various smoking cessation modalities. Individuals interested in quitting reported interest in using cessation modalities. Types of NRT were assessed individually; an NRT variable included nicotine patch/gum/lozenge/inhaler/nasal spray.
Interactions with HIV care providers
Participants reported whether their HIV care provider had ever encouraged them to quit smoking and whether they had suggested specific cessation modalities.
Participants responding yes to the latter reported all suggested modalities. Participants reported how often they discussed smoking cessation with their providers ("never-rarely;" "sometimes;" "often-always").
Statistical analysis
The sample included 275 individuals. Chi-square (χ 2 ) and t-tests described differences between groups based on interest in quitting smoking. Logistic regression analyses calculated adjusted odds ratios and 95% confidence intervals for associations between sample characteristics and interest in quitting smoking. Analyses were conducted using STATA SE statistical software version 12.0 (StataCorp, 2011).
Results
Sociodemographic and smoking characteristics
Half (49.1%) were interested in quitting smoking. Individuals interested in quitting were less likely to be daily smokers, χ 2 (1, N = 275) = 8.23, p = 0.004, and more likely to have made a quit attempt, χ 2 (1, N = 275) = 54.85, p < 0.001, compared to those not interested in quitting. Participant characteristics are found in Table 1 .
Reasons for wanting to quit
The most common reasons for wanting to quit smoking were to: be healthier (66.9%); live longer (59.5%); and feel better (57.1%) ( Table 2) . The most common "most important" reasons for wanting to quit smoking were to: be healthier (19.5%); live longer (14.3%); and avoid complications related to their HIV diagnosis (13.5%).
Lifetime use of, interest in, and suggested smoking cessation modalities
Forty-three percent reported lifetime use of NRT (Table 3) . Additionally, 29.1% of the sample attempted to quit by going cold turkey and 18.9% used behavioral methods. Use of bupropion (4.7%) and varenicline (3.6%) was low. Additionally, 15.6% of the sample used e-cigarettes while making a quit attempt. Among individuals interested in quitting, interest in using behavioral methods (59.8%), NRT (59.1%), and going cold turkey (56.1%) were high. Interest in bupropion (26.3%) and varenicline (27.0%) were among the lowest. Forty-four percent of those interested in quitting reported interest in using e-cigarettes.
Interactions with HIV care providers
A greater proportion of persons interested in quitting reported that their HIV care provider had encouraged them to quit smoking, χ 2 (1, N = 275) = 11.24, p = 0.001 and had suggested specific cessation modalities, χ 2 (1, N = 275) = 6.51, p = 0.011. Participants interested in quitting were more likely to discuss smoking cessation "often-always" with their provider, χ 2 (2, N = 275) = 12.52, p = 0.002. Additionally, 65.8% reported that their provider has suggested at least one cessation modality: NRT (70.7%), counseling (34.8%), and behavioral methods (32.0%) were most frequently recommended.
Logistic regression analyses
Daily smokers were 51% less likely (95% CI = 0.27-0.89) than non-daily smokers to be interested in cessation (Table 4 ). Participants who had made past quit attempt (s) were more likely to be interested in quitting (aOR = 10.50, 95% CI = 5.21-21.14). Individuals whose HIV care provider had encouraged them to quit smoking (aOR = 4.02, 95% CI = 1.62-9.97) and discussed smoking cessation "sometimes-always" (aOR = 2.25, 95% CI = 1.03-4.89) were more likely to be interested in quitting.
Discussion
Participants whose providers had encouraged them to quit were more likely to be interested in quitting than those whose providers had not (Berg et al., 2014) . Moreover, discussing smoking cessation "often-always" during healthcare visits doubled the likelihood of interest in quitting versus having discussions "never-rarely." This highlights the crucial role that healthcare providers play in promoting cessation. Some HIV-positive smokers (42%-65%) attempt cessation following diagnosis with HIV (Benard et al., 2007; Burkhalter, Springer, Chhabra, Ostroff, & Rapkin, 2005) ; time of diagnosis may be a Note: Values represent n (%) unless otherwise indicated. Bolded text indicates statistically significant differences. a n = 269 for these variables. window during which patients are willing to modify smoking behaviors. Findings emphasize the need for consistent smoking cessation intervention by healthcare providers.
NRT was the most commonly used (Pacek, Latkin, et al., 2014a) , garnered the greatest interest (Shapiro, Tshabangu, Golub, & Martinson, 2011; Shuter, Bernstein, & Moadel, 2012) , and was the most commonly recommended modality by healthcare providers. However, only 43% of the sample used NRT during a quit attempt. Relatively low use may be due to misinformation regarding nicotine's role in smoking-related morbidity among PLWH (Pacek, Rass, & Johnson, 2017) and misconceptions regarding NRT's safety (Mooney, Babb, Jensen, & Hatsukami, 2005) . Use of pill-based pharmacotherapies was uncommon (Pacek, Latkin, et al., 2014a) ; we observed lower interest in using and provider recommendations to use bupropion (Pacek, Latkin, et al., 2014b; Shuter, Bernstein, et al., 2012) and varenicline.
Although e-cigarettes are not currently an approved treatment for smoking cessation, 15.6% of participants used and 44% were interested in using e-cigarettes for cessation. Notably, 19.3% of participants whose provider had recommended cessation modalities had recommended e-cigarettes. Though proven cessation modalities should be promoted among PLWH, the tobacco control community should not discourage patients disinterested in such methods from switching to sole use of ecigarettes, particularly when taking a harm reduction approach.
In terms of limitations, data were collected via selfreport, and the cross-sectional design does not allow us to determine causality. Generalizability may be limited due to the online nature of the sample. Nevertheless, this study represents one of the first examinations of specific smoking cessation modalities recommended by HIV care providers (Konfino et al., 2012; Shuter, Bernstein, et al., 2012) and associations between provider characteristics and interest in cessation among PLWH.
This study provides a detailed examination of lifetime use of, interest in, and provider recommendations for smoking cessation modalities. Findings emphasize the importance of the healthcare provider-patient relationship for smoking cessation in PLWH. Findings highlight the need for consistent discussion of and encouragement regarding smoking cessation during healthcare visits, and cessation intervention training for clinicians.
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